A carregar...
The Development of Lonidamine for Benign Prostatic Hyperplasia and Other Indications
Lonidamine (LND) is a compound originally developed as an infertility drug. By capitalizing on the unique energy requirements of many solid tumors including benign prostatic hyperplasia (BPH), LND has shown efficacy as an adjunct to either radiation or chemotherapy in the treatment of several advanc...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MedReviews, LLC
2005
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1477628/ https://ncbi.nlm.nih.gov/pubmed/16986056 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|